莱茵生物事故致1死7伤，实控人被举报操纵股价 细节曝光

Group 1 - The core incident involved an explosion in a drying workshop of Rhine Biotech, resulting in 1 death, 3 serious injuries, and 4 minor injuries [2] - The company activated its emergency response plan and is cooperating with government authorities for rescue and investigation efforts [2] - The preliminary assessment of property damage from the incident is approximately 2 million yuan, but it is stated that the accident will not have a significant adverse impact on the company's future operations [5] Group 2 - Rhine Biotech specializes in the production and operation of natural health products, with stable revenue growth reported: 1.401 billion yuan in 2022, 1.494 billion yuan in 2023, and 1.772 billion yuan in 2024 [5] - The company has been actively conducting employee training, totaling 14,738 hours across various training programs in 2024 [6] - Recent allegations have surfaced against the actual controller of Rhine Biotech, Qin Benjun, regarding stock price manipulation, leading to administrative penalties including a 5-year market ban and fines totaling 276.36 million yuan [10]